Boothbay Fund Management, LLC Connect Biopharma Holdings LTD Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.8 - $1.65 $40,787 - $84,123
-50,984 Reduced 65.49%
26,867 $35,000
Q1 2022

May 16, 2022
BUY
$2.46 - $5.92 $118,490 - $285,148
48,167 Added 162.27%
77,851 $235,000
Q4 2021

Feb 14, 2022
BUY
$4.26 - $23.33 $126,453 - $692,527
29,684 New
29,684 $153,000

Others Institutions Holding CNTB

# of Institutions
12
Shares Held
3.05M
Call Options Held
0
Put Options Held
0
View Full List

About Connect Biopharma Holdings Ltd

CNTB Quotes by TradingView
  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $54.5M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email